- Home
- SBFM vs SXTP Comparison
SBFM vs SXTP Comparison
Compare SBFM & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBFM | SXTP |
|---|---|---|
| Founded | 2006 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3M | 3.6M |
| IPO Year | 2008 | 2023 |
Fundamental Metrics
Financial Performance| Metric | SBFM | SXTP |
|---|---|---|
| Price | $1.15 | $0.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $7.00 | ★ $14.10 |
| AVG Volume (30 Days) | ★ 393.8K | 51.1K |
| Earning Date | 04-03-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 36.77 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $36,305,891.00 | $1,005,471.00 |
| Revenue This Year | $40.47 | $33.92 |
| Revenue Next Year | N/A | $51.35 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 4.11 | ★ 65.49 |
| 52 Week Low | $0.25 | $0.34 |
| 52 Week High | $3.05 | $8.62 |
Technical Indicators
Market Signals| Indicator | SBFM | SXTP |
|---|---|---|
| Relative Strength Index (RSI) | 40.08 | 34.18 |
| Support Level | $1.09 | $0.45 |
| Resistance Level | $1.29 | $1.12 |
| Average True Range (ATR) | 0.09 | 0.09 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 40.07 | 16.45 |
Price Performance
Historical ComparisonAbout SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.